Biogen Inc. (LON:0R1B)
London · Delayed Price · Currency is GBP · Price in USD 149.78
+0.95 (0.64%)
At close: Oct 24, 2025
Biogen Market Cap
Biogen has a market cap or net worth of 16.52 billion as of October 27, 2025. Its market cap has decreased by -20.12% in one year.
Market Cap
16.52B
Enterprise Value
19.40B
Revenue
7.30B
Ranking
n/a
PE Ratio
14.79
Stock Price
149.78
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 89.21M to 16.52B, an increase of 18,415.92%. That is a compound annual growth rate of 16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 16.52B | -7.20% |
| Dec 31, 2024 | 17.80B | -39.53% |
| Dec 29, 2023 | 29.44B | -11.06% |
| Dec 30, 2022 | 33.10B | 27.16% |
| Dec 31, 2021 | 26.03B | -5.69% |
| Dec 31, 2020 | 27.60B | -31.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |